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rogressive motor neuronopathy
 
 (
 
pmn)
 
 mutant mice
have been widely used as a model for human moto-
neuron disease. Mice that are homozygous for the
 
pmn
 
 gene defect appear healthy at birth but develop
progressive motoneuron disease, resulting in severe skeletal
muscle weakness and respiratory failure by postnatal week
3. The disease starts at the motor endplates, and then leads
to axonal loss and ﬁnally to apoptosis of the corresponding
cell bodies. We localized the genetic defect in 
 
pmn
 
 mice to
a missense mutation in the 
 
tubulin
 
-
 
speciﬁc chaperone E
P
 
(Tbce)
 
 gene on mouse chromosome 13. The human
orthologue maps to chromosome 1q42.3. The 
 
Tbce
 
 gene
encodes a protein (cofactor E) that is essential for the form-
 
ation of primary 
 
 
 
-tubulin and 
 
 
 
-tubulin heterodimeric
complexes. Isolated motoneurons from 
 
pmn
 
 mutant mice
exhibit shorter axons and axonal swelling with irregularly
structured 
 
 
 
-tubulin and tau immunoreactivity. Thus, the
 
pmn
 
 gene mutation provides the ﬁrst genetic evidence that
 
alterations in tubulin assembly lead to retrograde degeneration
of motor axons, ultimately resulting in motoneuron cell death.
 
Introduction
 
Autosomal recessive traits of motoneuron disease are observed
in classical spinal muscular atrophy (SMA;* Lefebvre et al.,
1995), in SMA with respiratory distress type 1 (SMARD1;
Grohmann et al., 2001), and in a rare form of juvenile
amyotrophic lateral sclerosis (ALS2; Hadano et al., 2001;
Yang et al., 2001). The responsible gene defects have been
characterized; SMA and SMARD1 are caused by defects in
RNA processing. The discovery of gene defects in ALSIN/
ALS2, a GTPase with structural similarities to RanGEF as
well as RhoGEF in ALS2 (Hadano et al., 2001; Yang et al.,
2001), has given a first hint from human genetic studies that
signaling mechanisms regulating cytoskeletal turnover might
also be disturbed in motoneuron disease. Motoneurons dif-
fer from other types of neurons within the spinal cord by the
length of their axons, which can reach a length of 
 
 
 
1 m in
adult human. Structural and functional maintenance of
these large cells are dependent on the axonal transport of
organelles and cytoskeletal proteins. Deficiency or interruption
of axonal transport has been previously reported as a cause of
motoneuron disease (Cote et al., 1993; Xu et al., 1993;
LaMonte et al., 2002). However, in a significant number of
SMA and sporadic ALS cases, the underlying gene defects
have not yet been identified. Therefore, the characterization
of additional disease genes is expected to provide further
information on the pathophysiology of motoneuron disease.
The autosomal recessive 
 
progressive motor neuronopathy
 
(
 
pmn
 
) mouse mutant (Schmalbruch et al., 1991
 
)
 
 resembles
SMA by progressive degeneration of motoneurons in the
early postnatal period. Genetic mapping has identified the
 
pmn
 
 locus on mouse chromosome 13 in a region defined by
markers D13Mit172 and D13Mit207 (Martin et al., 2001).
We localized the genetic defect to a point mutation in the
 
tubulin
 
-
 
specific chaperone E
 
 (
 
Tbce
 
) gene affecting an evolu-
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tionary conserved amino acid residue. The identification of
this gene defect may help to define new candidate genes that
are mutated and thus might be involved in the pathophysiol-
ogy underlying human motoneuron disease.
 
Results and discussion
 
To identify the corresponding gene defect in 
 
pmn
 
 mice, we
have performed detailed genetic mapping by genotyping
229 
 
pmn/pmn
 
 F2 progeny from one male NMRI founder
that was heterozygous for the 
 
pmn
 
 gene defect and two fe-
male AKR mice. 29 microsatellite markers spanning a re-
gion of 31 cM were used and 34 recombination events
were observed (Fig. 1 A). Our results refined the 
 
pmn
 
 locus
to a 2-cM region flanked by markers D13Mit173 and
D13Mit207.
We generated a yeast artificial chromosome (YAC)– and a
bacterial artificial chromosome (BAC)–based physical map
of the genomic region encompassing nearly the entire 
 
pmn
 
candidate region (Fig. S1, available online at http://
www.jcb.org/cgi/content/full/jcb.200208001/DC1). Se-
quences from the ends of YAC and BAC clones were subse-
quently integrated into the complete sequence of the region
flanked by markers D13Mit173 and D13Mit207 when this
information became available in public and Celera data-
bases. The characterized region had a size of 
 
 
 
2.19 Mb. To-
gether with previously published data (Martin et al., 2001),
the critical region could be refined between D13Mit173 and
378J7-F, which is located between 
 
Pmn14
 
 and 
 
Mrpl32
 
 (Fig.
1 B; Table S1, available online at http://www.jcb.org/cgi/
content/full/jcb.200208001/DC1).
Comparative analysis of mouse and human homology
maps resulted in a transcript map of the 
 
pmn
 
 critical region
(Fig. 1 B; Table S1). Synteny with segments located on hu-
man chromosomes 1q42–q43 and 7p14.1–p13 was found,
as described earlier (Martin et al., 2001). We mapped 15
transcriptional units between D13Mit173 and 378J7-F and
23 between D13Mit173 and D13Mit237, including 11 pre-
viously characterized genes and 12 transcripts that all had
been identified before as EST in mouse and human. cDNA
Figure 1. Characterization of the gene defect in pmn mice. (A) Genetic map of the pmn candidate region. (B) Transcript map of the pmn 
region including the synteny region of the human genome. Transcriptional units not present in public databases were numbered according to 
their succession in this region. Pmn2 is located in noncoding regions of Nid. (C) Primary genomic DNA sequence of Tbce in pmn, heterozygous, 
and NMRI wt mice. Sequences of the sense strand are shown. The arrow indicates the T→G base mutation. The mutation leads to an exchange 
of the amino acid Trp to Gly. (D) Segregation of the homozygous Tbce
G/Tbce
G mutation with the pmn disease phenotype. One representative 
pedigree is shown. Homozygous Tbce
G/Tbce
G mutation was only found in pmn mice (black symbols). Healthy littermates were either 
heterozygous for the Tbce
G mutation (Tbce
W/Tbce
G; gray symbols) or homozygous wt (Tbce
W/Tbce
W; white symbols). The animals marked 
with a black dot showed symptoms of motoneuron disease but died before genotyping was initiated. 
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from brain of 
 
pmn/pmn
 
 and NMRI wild-type (wt) mice
was sequenced for all 11 previously characterized genes and
12 new transcripts to identify the possible mutation. Among
the 23 genes surveyed, only one gene was found to carry a
specific change in sequence, which was subsequently con-
firmed by sequencing genomic DNA from 
 
pmn
 
 mice. A
T
 
→
 
G transition occurred at nucleotide position 1682 of the
 
Tbce
 
 gene (Fig. 1 C). This results in a missense mutation ex-
changing tryptophan for glycine at position 524 of the mu-
rine cofactor E (CofE) protein. Sequence comparison re-
vealed that this amino acid is strictly conserved among verte-
brate species (Fig. 2). In nonvertebrate orthologues such as
 
Arabidopsis
 
 
 
thaliana
 
 and 
 
Caenorhabditis
 
 
 
elegans
 
, glutamate
and histidine are found instead of tryptophan at this posi-
tion. It is not clear whether this alteration correlates with
specific differences in chaperone function in tubulin assem-
bly between vertebrate and nonvertebrate species. At least
for the homologue of vertebrate cofactor A, such differences
have been proposed from genetic studies with 
 
Schizosaccha-
romyces pombe
 
 (Radcliffe et al., 2000).
To correlate this mutation with the 
 
pmn
 
 phenotype, we
analyzed 60 
 
pmn/pmn
 
 and 147 wt mice. These mice were
obtained from our breeding colony. They were not related
to the heterozygous male used for the initial backcross with
AKR. RT-PCR was performed with RNA from both the
brain and spinal cord. In addition, genomic DNA was inves-
tigated to rule out that the nucleotide exchange is due to
posttranscriptional mechanisms. This specific mutation in
both alleles in the 
 
Tbce
 
 gene clearly co-segregated with the
 
pmn
 
 disease phenotype. Healthy littermates were either het-
erozygous for the 
 
Tbce
 
 mutation or homozygous wt, accord-
ing to Mendelian rules (Fig. 1 D). In addition, mice with
NMRI, AKR, C57BL/6, or 129SvJ genetic background
were screened. In none of these mice, the T
 
→
 
G transition in
the 
 
Tbce
 
 gene was observed.
The protein encoded by the 
 
Tbce
 
 gene (CofE) plays an es-
sential role as a tubulin-specific chaperone that binds to
 
 
 
-tubulin and thus helps in its assembly with 
 
 
 
-tubulin
(Tian et al., 1996). This specific function is conserved between
species ranging from yeast (Hoyt et al., 1997; Radcliffe et
al., 1999) to mammals (Tian et al., 1997). During transla-
 
tion, tubulin subunits are folded to a quasi-native state by
the cytosolic chaperonin CCT (Hartl, 1996). The tubulin-
specific chaperones, which include CofE, subsequently as-
semble the native tubulin heterodimer. Therefore, distur-
bances of this process are expected to result in altered formation
of 
 
 
 
- and 
 
 
 
-tubulin heterodimers and should interfere with
assembly of microtubules. To test this hypothesis, we iso-
lated motoneurons from embryonic day 13.5 wt and 
 
pmn
 
mutant mice. The identification of the genetic defect in
 
pmn
 
 mice allowed us, for the first time, to genotype 
 
pmn/pmn
 
mouse embryos at day 13.5 and to distinguish them from wt
and heterozygous littermates. After a culture period of 7 d in
the presence of 1 ng/ml BDNF, the motoneurons were
fixed, stained with antibodies against tau and 
 
 
 
 III tubulin,
and the length of axonal processes was measured by observ-
ers who were blinded with respect to the genotype. In 
 
pmn
 
mutant motoneurons, both the length of the longest axon
and the total length of the axon including all its branches
(Fig. 3, A and B; Fig. 4, A and B) were significantly reduced,
by 58.77 
 
 
 
 1.25% and 64.76 
 
 
 
 3.66%, respectively (mean 
 
 
 
SEM, three independent experiments from nine 
 
pmn/pmn
 
and seven wt embryos).
Figure 2. Multiple amino acid sequence alignment of the COOH-
terminal region of CofE from different vertebrate and nonvertebrate 
species. The nucleotide sequences of CofE were taken from public 
databases, translated to the corresponding amino acid sequence, 
and then aligned using ExPasy (www2.ebi.ac.uk/clustal). The amino 
acid numbers correspond to murine CofE. Conserved substitutions 
and semiconserved substitutions are indicated in gray; the remaining 
black amino acids are identical. Amino acids without similarity are 
shown in light gray. The arrow indicates the amino acid mutated 
in pmn mice.
Figure 3. Axonal growth and survival in isolated wt and pmn 
mutant motoneurons. (A and B) After 7 d in culture with 1 ng/ml 
BDNF, the length of the longest axon and the total length of the 
axon including all its branches from pmn mutant motoneurons 
(Tbce
G/Tbce
G; open bar) are significantly (P   0.0001) shorter than 
from wt motoneurons (Tbce
W/Tbce
W; closed bar). (C) Survival of 
motoneurons isolated from wt (Tbce
W/Tbce
W;  ) and pmn mice 
(Tbce
G/Tbce
G;  ) in the presence (closed symbols) and absence 
(open symbol) of 1 ng/ml BDNF.566 The Journal of Cell Biology | Volume 159, Number 4, 2002
Moreover,  pmn mutant motoneurons exhibited axonal
swellings that were irregularly stained with antibodies against
  III tubulin and tau, whereas axonal swellings were only ob-
served in very few wt motoneurons (Fig. 4; Fig. 5, A–H). The
percentage of motoneurons with prominent axonal swellings
(more than threefold increase in axon diameter) was deter-
mined by a blinded observer, revealing a 20-fold increase in
this specific pathological feature in Tbce
G/Tbce
G mutant moto-
neurons (Fig. 4 C). The growth cones that are mostly devoid
of microtubular structures were morphologically indistin-
guishable in wt and pmn mutant motoneurons (Fig. 5, I–L).
Survival of wt and pmn mutant motoneurons was not dif-
ferent (Fig. 3 C). This finding indicates that the mutation in
the Tbce gene does not primarily affect motoneuron survival,
but disrupts axon growth and integrity. These data are in
agreement with previous observations that crossing of a bcl-2
transgene into pmn mice prevented the death of the moto-
neuron cell bodies but had no detectable effect on axon de-
generation, progressive muscle weakness, or time of death
(Sagot et al., 1995b).
To test whether the selectivity of the disease process is
caused by specific expression of Tbce in motoneurons, we
determined levels for Tbce mRNA by semiquantitative RT-
PCR in spinal cord, several brain regions, and other organs
of 3-wk-old mice. This time point was chosen because it re-
flects the most active stage of the disease process in pmn mu-
tant mice. Tbce seems ubiquitously expressed in the nervous
system and other organs, with no selectivity for spinal cord
(Fig. S2 A, available online at http://www.jcb.org/cgi/
content/full/jcb.200208001/DC1). Similar observations were
made when isolated embryonic motoneurons (E13.5) were
compared with cortical neurons (E13.5) or neural stem cells
derived from E11.5 mouse embryos (Fig. S2 B). Thus, the
disease process is not caused by specific expression of Tbce in
motoneurons, and the patho-mechanism underlying the
motoneuron disease in pmn mutant mice apparently is
caused by other means than specific Tbce gene expression.
This finding resembles observations in other forms of moto-
neuron disease, such as familial ALS and SMA. Neither Cu/
Zn superoxid dismutase nor Smn is specifically expressed in
motoneurons; therefore, the selectivity of the disease process
for motoneurons is still elusive.
We do not know yet how the Trp→Gly mutation at posi-
tion 524 of the CofE protein interferes with its cellular func-
tion. This mutation could destabilize the protein or lead to
either reduced or even enhanced chaperone activity, but it
may also change its subcellular distribution or alter its inter-
action with other cellular binding partners. Dysregulation of
CofE could interfere with tubulin assembly in several ways.
Loss of the CofE homologue Alp21 in S. pombe leads to se-
vere microtubule disintegration and reduced viability (Rad-
cliffe et al., 1999). Genetic inactivation of PFI, the ortho-
logue of the vertebrate Tbce in Arabidopsis, leads to defects
in microtubule organization, mitotic division, and cytokine-
sis, but does not primarily interfere with cellular survival
(Mayer et al., 1999; Steinborn et al., 2002).
Forced overexpression of CofE in Hela cells sequesters
 -tubulin, thus inhibiting dimer formation with  -tubulin and
destabilizing free  - and  -tubulin subunits (Bhamidipati et
al., 2000). Moreover, CofE, together with other tubulin-spe-
cific cofactors, can act as GTPase, converting GTP-tubulin
to GDP-tubulin. Thus, the capacity of polymerization into
microtubules is lost (Tian et al., 1999) either by overexpres-
sion, altered protein interactions, or loss of CofE.
Figure 4. Morphology of spinal motoneurons isolated from 13.5-d-old wt (Tbce
W/Tbce
W) 
and pmn (Tbce
G/Tbce
G) mutant embryos. Motoneurons were cultured for 7 d with 1 ng/ml 
BDNF, fixed, and stained against   III tubulin (red) and tau (green). (A and B) After 7 d 
in culture with 1 ng/ml BDNF, many Tbce
G/Tbce
G motoneurons exhibited axonal 
swellings (B, arrowheads), as defined by a locally restricted, irregular shaped, more than 
threefold increase in axon diameter. (A) wt (Tbce
W/Tbce
W) embryos. Bars, 50  M. (C) 
Blinded analysis of motoneurons from Tbce
W/Tbce
W (n   53) and Tbce
G/Tbce
G (n   55) 
mutant embryos revealed a  20-fold increase in the number of motoneurons with this 
specific alteration.Gene defect in pmn mice | Bömmel et al. 567
Microtubules play an important role in axonal transport
(Ishihara et al., 1999). The pmn mouse has been used in
many studies as an animal model for motoneuron disease.
Treatment of these mice with CNTF or other neurotrophic
factors delays axon degeneration and motoneuron cell death
(Sendtner et al., 1992; Haase et al., 1997). Neurotrophic
factors enhance axonal transport both in retrograde (Sagot et
al., 1998) and anterograde directions (Sahenk et al., 1994),
and thus, at least in part, could functionally compensate for
defects in microtubule structure in pmn mice (Sendtner et
al., 1992; Sagot et al., 1995a).
The pmn mice appear healthy during embryonic develop-
ment when axons grow out and make first contacts with
skeletal muscle, resembling the clinical phenotype of human
SMA. Thus, the function of CofE may become clinically rel-
evant after birth. However, we observe a significant reduc-
tion in axonal growth in isolated embryonic pmn motoneu-
rons. Nevertheless, the motoneurons still grow out axonal
processes, suggesting that mechanisms exist that can at least
partially compensate. This observation could reflect differ-
ential requirements of embryonic tubulin isoforms for CofE.
It will be interesting to find out whether the class III  -tubu-
lin isotype, which is highly expressed during development
but not in the adult (Ferreira and Caceres, 1992), does not
or to a lower degree depend on CofE.
Defects in microtubule function are associated with many
forms of neurodegenerative disease. Deletion of kinesin, a
microtubule-associated motor protein leads to severe moto-
neuron dysfunction in Drosophila (Hurd and Saxton, 1996).
In human, Charcot Marie Tooth disease type 2A is caused
by a mutation in the microtubule motor KIF1B  (Zhao et
al., 2001). Recently, it was shown that overexpression of dy-
namitin leads to disturbed retrograde axonal transport and
thus causes motoneuron disease in mice (LaMonte et al.,
2002). The symptoms are similar to those observed in mice
overexpressing neurofilament genes (Cote et al., 1993; Xu et
al., 1993). Moreover, mutations in tau, another microtubule
binding and stabilizing protein, are not only associated with
Figure 5. Morphology of spinal motoneurons isolated from 13.5-d-old wt (Tbce
W/Tbce
W) and pmn mutant (Tbce
G/Tbce
G) embryos. 
Motoneurons were cultured for 7 d with 1 ng/ml BDNF, fixed, and stained against   III tubulin (red) and tau (green). (A and B) Motoneurons 
derived from pmn mutant embryos (B) exhibit shorter axons compared with axons from control cells (A). In pmn mutant motoneurons axonal 
varicosities are detectable (B, arrowhead), which were rarely observed in wt motoneurons. (C–H) Whereas   III tubulin and tau immunoreactivity 
is regularly organized and evenly distributed in axonal branch points in motoneurons derived from wt embryos (C), immunoreactivity for   III 
tubulin and tau in pmn mutants (D–H) is irregularly distributed in aggregate-like structures, and both proteins do not colocalize. (I–L) In contrast, 
growth cones that are mostly devoid of microtubular structures are morphologically indistinguishable in wt (I and J) and pmn mutant 
motoneurons (K and L). Bars: (A and B) 25  m; (C, E, F, H) 5  m; (D and G) 25  m; (J and L) 5  m; (I and K) 25  m.568 The Journal of Cell Biology | Volume 159, Number 4, 2002
various forms of frontotemporal dementia (Garcia and
Cleveland, 2001; Goedert and Spillantini, 2001) but also
with the ALS/parkinsonism-dementia complex (Ishihara et
al., 1999). Thus dysfunction of cellular mechanisms regulat-
ing tubulin assembly plays an essential role in motoneuron
function and maintenance.
Materials and methods
Mouse strains
Two female AKR mice (Jackson ImmunoResearch Laboratories) and one
male NMRI founder heterozygous for the pmn gene defect were bred and
the F1 generation intercrossed for an F2 generation that could be used for
genetic mapping of the pmn locus. The pmn mutation has been first de-
tected at the Panum Institute (Kopenhagen, Denmark), where it spontane-
ously arose in a colony of NMRI outbred mice (Schmalbruch et al., 1991).
This line was continuously backcrossed to NMRI (Jackson ImmunoRe-
search Laboratories) at our animal facility, and mice from this colony were
used for confirmation of the Tbce gene mutation in pmn mice.
Genetic mapping of the pmn locus
Radioactive PCR with primers specific for the microsatellite markers was
performed. Recombination events were investigated by size polymor-
phisms of the resulting fragments. A total of 229 pmn/pmn F2 offspring
were genotyped with 29 microsatellite markers corresponding to a region
spanning 31 cM from D13Mit1 to D13Mit10. 34 crossovers were identi-
fied, allowing us to map the pmn locus in a 2-cM region of chromosome
13 between D13Mit173 and D13Mit207.
Physical mapping of the pmn locus
All YAC clones were obtained from Research Genetics. The BAC clones
were identified by screening of BAC mouse (release I and II) high-density
filters with probes corresponding to the genes for nidogen and Gli3. All
BAC clones were obtained from Genome Systems Inc., except BAC clone
369D23, which was supplied by Research Genetics. The physical map
was created by testing all BACs and YACs for the presence of markers
listed on the physical map and design of new sequence-tagged sites (STSs)
generated by YAC and BAC clone end sequences. The novel STS se-
quences are listed in Table S2, available online at http://www.jcb.org/cgi/
content/full/jcb.200208001/DC1.
Used databases
A Celera genomic scaffold covering  2.19 Mb (nucleotides 9,285,719–
11,297,173) located on mouse chromosome 13 was used to derive the
genomic structure of 23 putative and previously identified transcriptional
units.
Open reading frames were additionally confirmed using information de-
posited in public EST databases (www.ncbi.nlm.nih.gov/; Altschul et
al., 1997). Only sequences of expressed genes were analyzed. Homol-
ogy searches and sequence alignment were performed with BLAST
(www.ncbi.nlm.nih.gov/; Altschul et al., 1997).
Sequence analysis of candidate genes
Total RNA from tissue of pmn and wt mice was prepared by the Trizol pro-
cedure (Invitrogen) and was reverse transcripted with oligo dT primers ac-
cording to the manufacturer’s instructions (Invitrogen). Primers used for PCR
reactions and the specific PCR conditions are shown in Table S3, available
online at http://www.jcb.org/cgi/content/full/jcb.200208001/DC1.
Double-stranded DNA was subjected to automated sequencing on an
ABI 373 sequencer by dideoxy sequencing using a commercial standard
DNA sequencing kit (ABI). Both strands were sequenced with respective
primers. Resulting DNA sequences obtained from PCR products from pmn
and NMRI wt mice were aligned to corresponding sequence information
in databases in order to identify nucleotide variations.
Embryonic mouse motoneuron cultures
Spinal motoneurons from 13.5-d-old mouse embryos were isolated, en-
riched, and plated at a density of 3,000 cells/well on Greiner 4-well cul-
ture dishes as previously described (Wiese et al., 2001). Cells were grown
in neurobasal medium, B27 supplement, 10% horse serum, 500  M
glutamax (Invitrogen), and 1 ng/ml BDNF. Medium was first replaced at
day 1 and then every second day.
Surviving cells were counted under phase-contrast microscopy every
second day. Initial counting of plated cells was done when all cells were
attached to the culture dish at 4 h after isolation.
After 7 d in culture, motoneurons were fixed with 4% paraformalde-
hyde for 15 min at 4 C. The cells were washed with TBS (25 mM Tris/HCl,
pH 7.4, 0.8% NaCl, 0.2% KCl). Nonspecific binding sites were blocked for
1 h with TBS containing 10% goat serum and 0.1% Tween-20. Cells were
incubated for 24 h at 4 C with antibodies against   III tubulin (1:500; RDI)
and tau (1:200; Sigma-Aldrich), and then washed three times with TBS.  
III tubulin was visualized by goat anti–mouse Cy3 (5  g/ml; Jackson Immu-
noResearch Laboratories) and tau with goat anti–rabbit Cy2 (10  g/ml;
Jackson ImmunoResearch Laboratories) for 1 h. Cells were washed again
three times with TBS, and then covered with Mowiol in 50% glycerol/PBS
(vol/vol) and observed under a Leica confocal microscope (TCS; Leica).
Controls were done in the absence of the first antibodies (not depicted).
Digital photographs of motoneurons were taken using a Leica confocal
microscope. As previously described (Wiese et al., 1999), axons are at
least three times longer than dendrites after 7 d in culture and thus can be
distinguished. Axon length was determined by applying a morphometric
system (ScionImage; Scion Corporation, Inc.). These analyses of mutant
and wt motoneurons were performed blindly. The investigator did not
know the genotype of the cultured cells. Values from independent experi-
ments were pooled, and the results were expressed as the mean   SEM.
Statistical significance of differences were assessed by t test using the
GraphPad Prism software.
Neural stem cells
Cultures of neural stem cell neurospheres from forebrain of embryonic
day 11.5 mice were prepared and transferred to 100  l HBSS. After
treatment with trypsin (0.05%, 10 min; Worthington), cell suspensions
were generated by trituration. Trypsin was inactivated with trypsin inhib-
itor from egg yolk sack (0.05%; Sigma-Aldrich) and the cells plated on
75-ml culture dishes (Greiner) in 5 ml neurobasal medium containing
500  M glutamax, B27 supplement, and bFGF and EGF (Cell Concepts)
at final concentrations of 10 ng/ml each. Medium was changed every
second day. Cells from the supernatant were centrifuged at 400 g, tritu-
rated, and cultured in fresh medium. Cells were passaged at least six
times to enrich neurospheres. These neurospheres were centrifuged and
RNA was isolated.
Accession nos.
The GenBank/EMBL/DDBJ accession numbers for Mus musculus are as fol-
lows: NM031999 (Tm7sf1), NM 010917 (Nid), NM 010748 (Lyst), NM
010317 (Gng4), NM 010282 (Ggps1), AK018194 (Rbp1-like), AK002753
(Mrpl), NM 008944 (Psma2),  and X95255 (Gli3). The following accession
numbers are for Homo sapiens: NM 003193 (TBCE), NM 003272
(TM7SF1), NM 000081 (CHS1), 004485 (GNG4), NM 004837 (GGPS1),
NM 016374 (RBP1-like), XM 045232 (LOC94980), NM 031903 (MRPL32),
NM 002787 (PSMA2), NM 024054 (MGC2821), and BC021686 (ELF-1 ).
The accession number for Tbce is AV605313 for Bos taurus, BI314293
for Xenopus laevis,  AF486851 for A. thaliana, and NP 501395 for C. ele-
gans. The accession numbers from OMIM are as follows: 25330 (SMA),
604320 (SMARD1), 205100 (ALS2), and 118210 (Charcot Marie Tooth dis-
ease type 2A).
Online supplemental material
Figs. S1 and S2 and Tables S1, S2, and S3 are available online at http://
www.jcb.org/cgi/content/full/jcb.200208001/DC1. Fig. S1 shows the pmn
candidate region. Fig. S2 shows the expression profile of Tbce mRNA in
neuronal and nonneuronal tissue. Table S1 shows the transcript map of the
pmn region, including the syteny region of the human genome. Table S2
shows the novel STSs isolated from the pmn candidate region. Table S3
shows a list of primers used for PCR reactions.
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